Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Active not recruiting 5Unknown 2Terminated 2Withdrawn 1Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2CNS 1Breast 1

Conditions

Stomatitis 1Pancreatic Neoplasms 1Colorectal Neoplasms 1

Interventions

Oxaliplatin 288Capecitabine 218Fluorouracil 213Irinotecan 146Leucovorin 140Gemcitabine 124S 1 (combination) 110apatinib 109Cisplatin 102Bevacizumab 99Drug Therapy 98Radiotherapy 97Paclitaxel 97camrelizumab 89sintilimab 79Cetuximab 75lenvatinib 62Neoadjuvant Therapy 61tislelizumab 55Surgical Procedures, Operative 54Sorafenib 53Folfox protocol 53toripalimab 52Docetaxel 52130-nm albumin-bound paclitaxel 47Laparoscopy 41HMPL-013 40XELOX 39Radiosurgery 36Albumin-Bound Paclitaxel 36

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Losartan × Gastrointestinal × Clear all
NCT05871333 2023-07-19

Effect of Losartan on the Incidence and Severity of Chemotherapy-Induced Mucositis in Gastrointestinal Cancer Patients

Ain Shams University

Phase 2 Unknown
80 enrolled
Gastrointestinal

Stomatitis, Colorectal Neoplasms

NCT01821729 2020-09-25

Proton w/FOLFIRINOX-Losartan for Pancreatic Cancer

Massachusetts General Hospital

Phase 2 Unknown
50 enrolled 11 charts
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡